- Home
- XOMA vs LAB Comparison
XOMA vs LAB Comparison
Compare XOMA & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOMA
- LAB
- Stock Information
- Founded
- XOMA 1981
- LAB 1999
- Country
- XOMA United States
- LAB United States
- Employees
- XOMA N/A
- LAB N/A
- Industry
- XOMA Biotechnology: Pharmaceutical Preparations
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- XOMA Health Care
- LAB Industrials
- Exchange
- XOMA Nasdaq
- LAB Nasdaq
- Market Cap
- XOMA 457.6M
- LAB 504.2M
- IPO Year
- XOMA N/A
- LAB 2011
- Fundamental
- Price
- XOMA $34.88
- LAB $1.30
- Analyst Decision
- XOMA Strong Buy
- LAB Buy
- Analyst Count
- XOMA 2
- LAB 2
- Target Price
- XOMA $69.50
- LAB $2.50
- AVG Volume (30 Days)
- XOMA 52.1K
- LAB 1.4M
- Earning Date
- XOMA 11-06-2025
- LAB 11-11-2025
- Dividend Yield
- XOMA N/A
- LAB N/A
- EPS Growth
- XOMA N/A
- LAB N/A
- EPS
- XOMA N/A
- LAB N/A
- Revenue
- XOMA $44,952,000.00
- LAB $172,271,000.00
- Revenue This Year
- XOMA $88.91
- LAB N/A
- Revenue Next Year
- XOMA $13.80
- LAB N/A
- P/E Ratio
- XOMA N/A
- LAB N/A
- Revenue Growth
- XOMA 194.98
- LAB 76.33
- 52 Week Low
- XOMA $18.35
- LAB $0.92
- 52 Week High
- XOMA $39.92
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- XOMA 45.06
- LAB 48.34
- Support Level
- XOMA $34.25
- LAB $1.26
- Resistance Level
- XOMA $39.00
- LAB $1.47
- Average True Range (ATR)
- XOMA 2.00
- LAB 0.08
- MACD
- XOMA -0.56
- LAB -0.00
- Stochastic Oscillator
- XOMA 11.11
- LAB 16.67
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.